newdrugapprovals.org
Sihuan Pharma’s clinical study application for oncology drug Pirotinib accepted by CFDA
The China Food and Drug Administration (CFDA) has accepted Sihuan Pharmaceutical’s application for clinical trial approval for its Pirotinib, a Category 1.1 innovative oncology drug developed…